Replies to post #36684 on Biotech Values

[ThomasS]

Albuferon results: They don't look impressive to me.
13% ?
And, when they speak of "non-responders," are they speaking exclusively of patients who completed a prior 48-week course with a different interferon/riba regime, or, also including patients who did not complete the entire 48 weeks? ("non responders" are usually weeded out within 12 weeks, or are grouped in that class if they stop for other reasons, such as side-effects)
If they are including patients, who say did 8 weeks previously but stopped for whatever reason... well then that skews the Albuferon results (which were for only a completed 48-week regime)